Trials / Recruiting
RecruitingNCT05884892
Egyptian Hypertrophic Cardiomyopathy Program
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Magdi Yacoub Heart Foundation · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Egyptian HCM program aims at defining incidence, severity, phenotype, genotype and determinants of the disease in Egypt, and providing state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific.
Detailed description
This project aims to: * Define incidence, severity, phenotype, genotype and determinants of the disease in Egypt. * Characterise the phenotype and genotype of several large cohorts with inherited muscle disease and their relatives. * Provide state-of-the-art treatment strategies including medical, surgical and interventional procedures which are patient- and disease-specific. * Study the basic mechanisms responsible for the different phenotypes at a molecular and cellular level including genotype-phenotype correlation. * Provide a special focus for studying patients who are genotype positive and phenotype negative which we believe could yield critical data regarding the evolution of the disease. * Develop sophisticated laboratory studies for single cell electrophysiology and immunocytochemistry and others focusing on the explanted human material from the surgical program. * Define the role of microvascular coronary artery in the development and progression of the disease. * Training Egyptian cardiologists, cardiac surgeons and scientists on state-of-the-art diagnosis and management of heart muscle disease including the latest developments in imaging, novel surgical techniques, coronary physiology, next generation sequencing, bioinformatics and cellular electrophysiology.
Conditions
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2030-01-01
- Completion
- 2030-01-01
- First posted
- 2023-06-01
- Last updated
- 2023-06-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05884892. Inclusion in this directory is not an endorsement.